Effects of Glycopyrronium Bromide (GB) Delivered Via a Pressurized Metered-Dose Inhaler (pMDI) in Subjects with Chronic Obstructive Pulmonary Disease (COPD) on Cardiovascular Parameters: Results from the GLIMMER Study

被引：0
|
作者：
Kerwin, E. M. [1 ]
Feldman, G. [2 ]
Beaudot, C. [3 ]
Georges, G. [4 ]
机构：
[1] Clin Res Inst, Medford, OR USA
[2] South Carolina Pharmaceut Res, Spartanburg, SC USA
[3] Chiesi USA Inc, Cary, NC USA
[4] Chiesi USA, Global Clin Dev, Cary, NC USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A7371
引用
收藏
页数：2
相关论文
共 45 条
  • [41] A phase IIb randomized, chronic-dosing, incomplete block, cross-over study of glycopyrronium, delivered via metered dose inhaler, compared with a placebo and an active control in patients with moderate-to-severe COPD
    Edward M. Kerwin
    Selwyn Spangenthal
    Christine Kollar
    Earl St Rose
    Colin Reisner
    Respiratory Research, 19
  • [42] Cardiovascular events after exacerbations of chronic obstructive pulmonary disease: Results from the EXAcerbations of COPD and their OutcomeS in CardioVascular diseases study in Italy
    Calabria, Silvia
    Ronconi, Giulia
    Dondi, Letizia
    Dondi, Leonardo
    Dell'Anno, Irene
    Nordon, Clementine
    Rhodes, Kirsty
    Rogliani, Paola
    Dentali, Francesco
    Martini, Nello
    Maggioni, Aldo Pietro
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 127 : 97 - 104
  • [43] Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease
    Kosoglou, Teddy
    Hubbell, James
    Xuan, Fengjuan
    Cutler, David L.
    Meehan, Alan G.
    Kantesaria, Bhavna
    Wittmer, Bret A.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2013, 8 : 107 - 116
  • [44] Cardiovascular Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Chronic Obstructive Pulmonary Disease (COPD): A 24-Hour Hotter Monitoring Sub-Study of the ETHOS Trial
    Ferguson, G. T.
    Rabe, K. F.
    Martinez, F. J.
    Trivedi, R.
    St Rose, E.
    Ballal, S.
    Darken, P.
    Aurivillius, M.
    Dorinsky, P.
    Reisner, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [45] Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD
    Doherty, Dennis E.
    Tashkin, Donald P.
    Kerwin, Edward
    Knorr, Barbara A.
    Shekar, Tulin
    Banerjee, Sibabrata
    Staudinger, Heribert
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2012, 7 : 57 - 71
12345